You have 9 free searches left this month | for more free features.

Shengxuening tablet

Showing 1 - 25 of 3,216

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

Recruiting
  • Hematological Malignancy
  • Cancer-Related Anemia
  • Shengxuening Tablet
  • Ferrous succinate
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Mar 13, 2023

Bioavailability Trial in Montréal (Filgotinib)

Not yet recruiting
  • Bioavailability
  • Montréal, Canada
    Altasciences
Sep 12, 2023

Technology, Cognitive Impairments, Intellectual Disability Trial in Hong Kong (Tablet-based interactive games experimental group

Not yet recruiting
  • Technology
  • +2 more
  • Tablet-based interactive games experimental group intervention
  • Hong Kong, Hong Kong
  • +4 more
Apr 18, 2023

Acute Pain, Postoperative Pain Trial in Oaxaca (etoricoxib-tramadol, Naproxen, Tramadol)

Completed
  • Acute Pain
  • Postoperative Pain
  • Oaxaca, Mexico
    Oaxaca Site Management Organization
Aug 10, 2023

Healthy Participants Trial in Cypress (Semaglutide J, Semaglutide C)

Recruiting
  • Healthy Participants
  • Semaglutide J
  • Semaglutide C
  • Cypress, California
    Novo Nordisk Investigational Site
Mar 28, 2023

Graft-versus-host Disease Trial in Beijing (SHR0302)

Not yet recruiting
  • Graft-versus-host Disease
  • Beijing, Beijing, China
    Beijing Hospital
May 4, 2023

Healthy Participants Trial in Lincoln (AB521)

Recruiting
  • Healthy Participants
  • Lincoln, Nebraska
    Celerion, Inc.
Aug 22, 2023

Healthy Volunteer Trial (Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet, Lumacaftor 200 mg Film-Coated Tablet

Not yet recruiting
  • Healthy Volunteer
  • Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
  • Lumacaftor 200 mg Film-Coated Tablet Formulation
  • (no location specified)
Jul 21, 2023

Healthy Trial (Drug: PF-07817883)

Not yet recruiting
  • Healthy
  • Drug: PF-07817883
  • (no location specified)
Nov 2, 2023

Healthy Participants Trial in Montreal (Semaglutide)

Recruiting
  • Healthy Participants
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Oct 18, 2023

Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)

Not yet recruiting
  • Healthy Volunteers
  • BMS-986419 DR Capsule
  • BMS-986419 IR Tablet
  • (no location specified)
Jul 20, 2023

Safety of Envlo Tablet in Type II Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jun 22, 2023

Hyperlipidemias Trial in Qingdao (ezetimibe tablet, ezetimibe tablet(Ezetrol ®))

Completed
  • Hyperlipidemias
  • ezetimibe tablet
  • ezetimibe tablet(Ezetrol ®)
  • Qingdao, Shandong, China
    Clinical Research Center
Dec 27, 2022

Sleep, Sleep Hygiene Trial (Timed evening technology and digital media use (tablet use), no technology and digital media use

Not yet recruiting
  • Sleep
  • Sleep Hygiene
  • Timed evening technology and digital media use (tablet use)
  • no technology and digital media use (screen media use)
  • (no location specified)
Apr 7, 2023

Diabetes, Type 2 Trial in San Antonio (Oral semaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Nov 18, 2022

Diarrhea-Predominant Irritable Bowel Syndrome Trial (Changyanning tablet, Changyanning tablet )

Not yet recruiting
  • Diarrhea-Predominant Irritable Bowel Syndrome
  • Changyanning tablet
  • Changyanning tablet placebo
  • (no location specified)
Jan 13, 2023

Healthy Participants Trial in Neuss (Semaglutide)

Not yet recruiting
  • Healthy Participants
  • Neuss, Germany
    Novo Nordisk Investigational Site
Aug 10, 2023

Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)

Completed
  • Hypertension
  • baxdrostat (formerly CIN-107) oral solution
  • Cincinnati, Ohio
    Medpace
Jul 18, 2023

Healthy Individuals Trial in Karachi (Test Drug, Reference Drug)

Recruiting
  • Healthy Individuals
  • Test Drug
  • Reference Drug
  • Karachi, Sindh, Pakistan
    Muhammad Raza Shah
Dec 18, 2022

Healthy Trial in Fukuoka (JNJ-77242113, Placebo)

Completed
  • Healthy
  • Fukuoka, Japan
    Souseikai Hakata Clinic
Nov 22, 2022

Safety, Bioavailability, Pharmacokinetics Trial in Ljubljana (Linaprazan glurate)

Completed
  • Safety
  • +2 more
  • Linaprazan glurate
  • Ljubljana, Ukmarjeva Ulica 6, Slovenia
    CRS d.o.o.
Jan 17, 2023

Healthy Trial in Seoul (Acetaminophen)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Jan 3, 2023

A Game-based Neurodevelopmental Assessment for Young Children

Recruiting
  • Neurodevelopmental Disorders
  • +5 more
  • Tablet Game-based Assessment
  • +2 more
  • London, United Kingdom
    Brightlobe Limited
Mar 10, 2023

Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)

Not yet recruiting
  • Healthy
  • Y-2 Sublingual Tablet
  • Placebo
  • Glendale, California
    Parexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023

COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in India (Ramatroban, Placebo)

Recruiting
  • COVID-19 Pneumonia
  • COVID-19 Respiratory Infection
  • Nellore, Andhra Pradesh, India
  • +6 more
Jan 28, 2023